Home › Compare › KPV vs LL-37
KPV vs LL-37
KPV sits in healing & recovery, while LL-37 sits in immune — so despite being mentioned together they are used for different things. The table below sets out the differences. We give no dosing guidance.
Side by side, in plain English — what each one is, where they overlap and where they genuinely differ.
KPVHealing & Recovery
LL-37ImmuneAt a glance
| KPV | LL-37 | |
|---|---|---|
| Category | Healing & Recovery | Immune |
| Typical route | SubQ (or oral) | SubQ |
| Shelf life once mixed | ~30 days | ~30 days |
| Commonly reported effects | Reduced inflammation IBD relief Skin healing | Broad antimicrobial Wound healing Immune boost |
| Reported considerations | Very few reported | Injection site irritation |
The differences that actually matter
They aren't really substitutes: KPV sits in Healing & Recovery while LL-37 sits in Immune. People usually pick between them because of a shared secondary effect rather than because they do the same job.
Route of administration differs — KPV is typically subq (or oral), LL-37 is typically subq. That alone changes how convenient each one is to keep up with.
Where they overlap: skin healing.
Reported mainly for KPV: reduced inflammation, ibd relief.
Reported mainly for LL-37: broad antimicrobial, immune boost.
What KPV is
KPV is a tripeptide fragment derived from the C-terminus of alpha-melanocyte stimulating hormone (alpha-MSH). Research indicates its primary mechanism involves potent anti-inflammatory effects. It is thought to exert its actions, in part, by interacting with melanocortin receptors, particularly MC1R, which are present on various cell types including immune cells and epithelial cells. This interaction can modulate intracellular signaling pathways, such as the inhibition of NF-κB activation, leading to a reduction in
What LL-37 is
LL-37 is a human cathelicidin antimicrobial peptide, a component of the innate immune system. Its mechanism of action involves direct disruption of microbial membranes, providing broad-spectrum antibacterial and antiviral activity. Beyond this direct action, LL-37 acts as a signaling molecule, interacting with various cellular receptors, including G-protein coupled receptors like FPR2, to modulate immune responses. This interaction can influence processes such as chemotaxis, angiogenesis, and cytokine production. B
How to compare them for yourself
Anecdotes online are noisy because nobody is measuring the same thing. The only comparison that means anything is your own: log each entry with a timestamp, keep the vial ledger honest so you know what you actually got through, pick two or three metrics before you start, and look at the trend after several weeks rather than day to day.
Peptide Wizard does that part for you — KPV and LL-37 are both in the built-in reference library with a 3D vial, and your history, vial ledger and cost per entry stay private on your device.
FAQ
What is the difference between KPV and LL-37?
They aren't really substitutes: KPV sits in Healing & Recovery while LL-37 sits in Immune. People usually pick between them because of a shared secondary effect rather than because they do the same job.
Can you log KPV and LL-37 in the same period?
Plenty of people record more than one peptide at a time. Peptide Wizard keeps a separate vial ledger and entry history for each, so you can see exactly what overlapped and when — it does not recommend combinations or doses.
Which is better, KPV or LL-37?
There isn't a universal answer — reported responses vary a lot between individuals, which is why your own log is more informative than anyone else's anecdote. Track one variable at a time and compare your own metrics over several weeks.
Is this medical advice?
No. This page is educational reference material only. It contains no dosing guidance. Speak to a qualified healthcare professional before making any decisions.
See all peptide comparisons →
Educational reference only. This page contains no dosing guidance and is not medical advice.